Back to trial details

Intake questionnaire

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Applying to University of California LA · Los Angeles, California

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 100 years old?
2. Have you been diagnosed with Advanced HR+/HER2- Breast Cancer?
3. Are you able to travel to Los Angeles for study visits?